Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Out Summer 2017)


Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!


Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.


I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC (http://www.videolan.org) to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (http://www.videolan.org).


Affichage des articles dont le libellé est GIVE YOUR DATA. Afficher tous les articles
Affichage des articles dont le libellé est GIVE YOUR DATA. Afficher tous les articles

" Genentech signs five-year collaboration with Patients Like Me for patient data"


J&J Opens Data Vault to Yale, in ‘Unprecedented’ Transparency Move


"Would u publish your latest research findings as a Tweet? You can now."


"Realities of data sharing using the genome wars"

"The purpose of this article is to examine one process of data sharing in detail in the hope that the problems and successes can inform the system more generally." 

Realities of data sharing using the genome wars: as case study - an historical perspective and commentary

 ==> Download case study as PDF (15 pages) here.

J. Craig Venter: "Cool article on data sharing, Celera and the Genome Wars by veteran"

The future of evidence based medicine

Become a Data Donor!

The DNA Microcredit Revolution: Donate your Data in India thanks to microcredit


https://www.facebook.com/catherine.coste



Meet the Made-in-India Cancer Genome Project: Donate your DNA data, thanks to microcredit
Microfinance for DNA Data Sharing
Using Microcredit (microfinance) for some made-in-India Human Cancer Genome Project?
Wanna get some better, affordable and personalized medicine?
MICROCREDIT YOUR DNA!

We can donate our vital organs upon our death... Now it seems that we can even donate... our data.

"Our project aims to enable citizens to donate their data upon their death."

http://prayformedicine.blogspot.fr

But... why wait for somebody's death??

I dunno if you are familiar with India and Bangladesh -- well I am a tiny bit. You find people all over the place, willing to sell their hair (women, for the worldwide hair extension market), their blood, a kidney (er that one falls under the organ trafficking category), etc.

Now how about cancer and healthy (but not wealthy) patients who could trade their DNA data for some rice or medicine or... a microloan?

Remember the microcredit (microfinance)? Muhammad Yunus was awarded the Nobel Peace Prize in 2006 for his work providing microcredit services to the poor.

Would you rather give your data, or... a vital organ?

The speed of progress in the human genome science is mind blowing... However, curing cancer will request a lot of sharing work from patients worldwide... India is a good place to start... 

Big Pharma / Big Biotech are both powerful and greedy. Any power calls for a counter-power. With no counter-power at all, "big pharma" is very likely to turn into "pig pharma" -- consuming Chinese human guinea pigs, that is...

"Medical student Pia Grazdani decides to take a year off from her studies and escape New York City. Intrigued by the promise of the burgeoning field of medical technology, Pia takes a job at Nano, LLC, a lavishly funded, security-conscious nanotechnology institute in the picturesque foothills of the Rocky Mountains in Colorado. Nano, LLC is ahead of the curve in the competitive world of molecular manufacturing, including the construction of microbivores, tiny nano-robots with the ability to gobble up viruses and bacteria. But the corporate campus is a place of secrets. When Pia encounters a fellow employee on a corporate jogging path suffering the effects of a seizure, she soon realizes she may have literally stumbled upon one of Nano, LLC's human guinea pigs. Is the tech giant on the cusp of one of the biggest medical discoveries of the twenty-first century – a treatment option for millions – or have they already sold out to the highest bidder?" (Amazon)
http://www.truthdig.com/cartoon/item/made_in_bangladesh_20130509

http://tablenumbersix.wordpress.com/2013/06/17/dna-sequencing-an-opportunity-for-breakthroughs-in-science/

Eric Lander PhD, Geneticist: "Please share your data! The Cancer Genome Project."

MITx 7.00 MOOC "Intro to Biology - The Secret of Life". Lecture week 13.Instructor: Eric Lander PhD.


Eric Lander, PhD, involved in the Human Genome Project, MIT Professor:

"What has been so cool, in the past four or five years, as we talked about DNA sequencing, it's gotten so cheap that you could sequence every patient's own cancer and compare it to their normal DNA. And find that patient's mutations. And you can imagine a world where every patient will have their genome sequenced and their tumor sequenced. And a physician could use that information, as we collect more of it, to figure out which drugs to be using in which combinations. And that's a world we're all imagining right now, a world where that could happen. It's going to take a lot of work to get there. And in my opinion, it's going to take a lot of sharing.

Because we're going to need information pooled from patients around the world. Because we're going to have to learn which patients respond well to which drugs as a function of which mutations they have. And if they have a relapse and the cancer becomes resistant to the drug, which mutations have happened? We're going to need to pool all that, which means I think we're going to need to have some kind of common, agreed upon data sharing mechanisms where patients can voluntarily-- it's up to them-- but voluntarily say, 'count me in. I'm willing to share my data with other people sharing their data so we can build a big enough data set that we can learn what works best.' And I wouldn't be surprised over the next couple of years we see a kind of alliance across many institutions in the world and patients in many countries to try to create that knowledge base. It's kind of like a human cancer Genome Project, but where it's the humans who are involved who are doing it, or the patients who are doing it. And I think it's going to be a really important thing."

MITx 7.00 MOOC "Intro to Biology - The Secret of Life". Lecture week 13.

Cutting-Edge Medical Researchers Say Their Projects Break Big Data Ceiling